China Appetite For HPV Vaccine Delivers Surprise For Merck
Executive Summary
When Merck realized that demand in China is so large for its HPV vaccine Gardasil, the US company wanted to understand more about the market, but a coordinated pre-launch awareness campaign appears to have helped.
You may also be interested in...
Gardasil Set For Further Growth As England Okays HPV Vaccine For Boys
The decision to expand the HPV vaccination program in England to boys comes as Merck & Co sees "an unprecedented increase in global demand" for Gardasil.
Shingrix Gets China Nod But Won’t Launch Until 2020 Amid Strong Demand
Following a priority review, Shingrix may become the next hit vaccine in China as millions seek preventative care, but GSK is being cautious over supply plans.
Calm Before The Storm: Pharma Opens 2019 With A Bang In China
Products old, new and reimbursed were the driving force for foreign drug firms including AstraZeneca, Merck and Pfizer and Sanofi to smash growth in China in the first quarter.